Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients — Stella
Study to Evaluate Safety and Efficacy of Different PANZYGA Dose Regimens in Pediatric Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) Patients
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(6 sites)
United States
Octapharma Research Site, Birmingham, Alabama
Octapharma Research Site, Orange, California
Octapharma Research Site, Louisville, Kentucky
Octapharma Research Site, Philadelphia, Pennsylvania
Octapharma Research Site, Houston, Texas
Octapharma Research Site, Charlottesville, Virginia